The oral microbiota influences health and disease states. Some gram-negative anaerobic bacteria play important roles in tissue destruction associated with periodontal disease. Lactoferrin (LF) and lactoperoxidase (LPO) are antimicrobial proteins found in saliva; however, their influence on the whole oral microbiota currently remains unknown. In this randomized, double-blinded, placebocontrolled study, the effects of long-term ingestion of LF and LPO-containing tablets on the microbiota of supragingival plaque and tongue coating were assessed. Forty-six older individuals ingested placebo or test tablets after every meal for 8 weeks. The relative abundance of bacterial species was assessed by 16S rRNA gene high-throughput sequencing. Most of the bacterial species in supragingival plaque and tongue coating that exhibited significant decreases in the test group were gram-negative bacteria, including periodontal pathogens. Decreases in the total relative abundance of gram-negative organisms in supragingival plaque and tongue coating correlated with improvements in assessed variables related to oral health, such as oral malodor and plaque accumulation. Furthermore, there was significantly less microbiota diversity in supragingival plaque at 8 weeks in the test group than in the placebo group and low microbiota diversity correlated with improvements in assessed variables related to oral health. These results suggest that LF and LPO-containing tablets promote a shift from a highly diverse and gram-negative-dominated to a gram-positive-dominated community in the microbiota of supragingival plaque and tongue coating. This microbial shift may contribute to improvements in oral health, including oral malodor and state of the gingiva.
paper by the Research, Science and Therapy Committee of the American Academy of Periodontology (6) . Therefore, development of safe and daily methods for oral care is needed to enable maintenance of healthy conditions and microbial homeostasis, particularly in older individuals.
LF and LPO are glycoproteins found in saliva, milk and other exocrine secretions (7) (8) (9) . LF has been shown to exert in vitro antimicrobial effects against oral pathogens such as Porphyromonas gingivalis, and antibiofilm effects against P. gingivalis and Prevotella intermedia (7) . LPO catalyzes the hydrogen peroxidedependent oxidation of thiocyanate (SCN À ) to hypothiocyanite (OSCN À ), which exerts bactericidal effects on periodontal pathogenic bacteria (10) and inhibitory effects on bacterial lyases related to the production of oral malodor (11) . Because they have these properties, LF and LPO have been used in oral health care products and foods (12, 13) . Morita et al. have shown that long-term ingestion of LF and LPO-containing tablets significantly reduces the number of P. gingivalis and Fusobacterium nucleatum in supragingival plaque and tongue coating in older individuals (14) . These findings suggest that LF and LPO have the potential to suppress several oral pathogens. Targeted DNA sequencing of bacterial 16S rRNA gene regions recently revealed relationships between oral health-related conditions and the oral microbiota (15, 16) . However, the effects of LF and LPO on the whole oral microbiota have not yet been examined in detail. In the present study, we used 16S rRNA gene high-throughput sequencing to assess the effects of LF and LPO on the microbiota of supragingival plaque and tongue coatings collected in a previous clinical trial conducted by Morita et al. (14) .
MATERIALS AND METHODS

Study design
This single-center, randomized, double-blinded, placebocontrolled, parallel group comparative study was performed in Japan and was conducted in accordance with the Helsinki Declaration of 1975 and as revised in 2013. The study design was reviewed and approved by the research Ethics Committee of the School of Dentistry, Showa University (No. 2014-016) . This study was enrolled in the UMIN clinical trial registration system (ID: UMIN000015706).
Forty-seven subjects were recruited and screened after providing informed consent. Inclusion criteria were adults aged 65 years and older with tongue coating. Exclusion criteria were as follows: (i) eating pureed and finely-chopped meals; (ii) receiving parenteral nutrition; (iii) receiving treatment for dental disease (except adjustment of dentures, oral hygiene instructions); (iv) history of allergy to milk; (v) received antibiotic treatment in the past 1 month, or expected to receive it in the near future; (vi) use of oral care products for prevention of oral malodor or improvement of oral hygiene; (vii) regular consumption of LF or LPOcontaining food or oral care products; and (viii) presence of exacerbating diseases of the liver, kidney, heart, lung, gastro-intestine, blood, endocrine system, and metabolic system.
The test tablets contained 80 mg of LF þ LPO powder (Orabarrier; Morinaga Milk Industry, Tokyo, Japan) including the active ingredients of 20 mg of LF, 2.6 mg of LPO and 2.6 mg of glucose oxidase. LF and LPO had been purified from bovine milk. Glucose oxidase was obtained from Penicillium chrysogenum. The LF þ LPO powder also contained glucose and pH-adjusting agents that support the effects of the active ingredients. The placebo tablets contained dextrin and coloring materials instead of LF þ LPO powder. These placebo and test tablets were identical in weight, texture and appearance and were of readily soluble perforated type to prevent asphyxia and aspiration. Participants were randomly assigned to receive either placebo or test tablets and asked to suck a tablet after every meal for 8 weeks. They were instructed not to change their oral hygiene regimens throughout the study period.
Oral assessments
Oral assessments were conducted 2 hr after lunch at baseline, 4 and 8 weeks. Three trained and calibrated dentists performed the following assessments: O'Leary's PCR (17) , PPD, BOP (18) and total VSCs in oral air (19) . O'Leary's PCR, PPD, and BOP were all measured in every tooth. PPDs were recorded as the deepest pocket depth to the nearest millimeter. Concentrations of VSCs in oral air were analyzed with a portable gas chromatography device (OralChroma; FIS, Itami, Japan) according to the manufacturer's instructions (19) . The concentration of total VSCs is expressed as the sum of hydrogen sulfide, methyl mercaptan and dimethyl sulfide concentrations.
Collection of oral samples and DNA extraction
Tongue coating and supragingival plaque were collected using sterile swabs (Puritan Medical Products, Guilford, ME, USA) under constant pressure. Tongue coating was collected from a 2 cm 2 area in the mid-dorsum of the tongue and supragingival plaque was taken from the cervical region on the buccal surface of maxillary molars.
Milk proteins and the oral microbiota
The swabs were suspended in 1 mL sterile saline stored in vials (20) . The same sampling site was used at all sampling times in each subject. Bacterial DNA was extracted from the samples using a commercial kit (QIAamp; Qiagen, Hilden, Germany) according to the manufacturer's protocol and the remainder of each sample inoculated on to Sabouraud agar (BD-Pharmingen, San Diego, CA, USA) to detect Candida sp. Following incubation for 48 hr in a 5% CO 2 atmosphere, Candida sp. was identified using a commercial kit (Candida Check; LSI Medience, Shimura, Japan).
PCR amplification and DNA sequencing of bacterial 16S rRNA A 16S rRNA gene sequencing analysis was performed as described previously, with minor modifications (21) . The V1-V2 region of bacterial 16S rRNA genes was amplified using PCR with a TaKaRa Ex Taq HS kit (TaKaRa Bio, Shiga, Japan) and the primer set of Tru27F (5 0 -CGCTCTTCCGATCTCTGAGRGTTTGATYMTGGCT-CAG-3 0 ) and Tru354R (5 0 -CGCTCTTCCGATCTGACCT GCCTCCCGTAGGAGT-3 0 ). DNA was amplified according to the following program: 94°C for 3 min; 30 cycles of 94°C for 30 s, 50°C for 30 s, and 72°C for 30 s; 72°C for 5 min. After verifying amplified DNA using the QIAxcel system (Qiagen, Valencia, CA, USA), triplicate samples were combined. One microliter samples of combined PCR products were amplified using the following barcoded primers adapted for the Illumina MiSeq:
0 , where X represents a barcode base. DNA was amplified according to the program described above, except that only eight cycles were conducted. After validating the second amplified DNA product with the QIAxcel system, PCR products were purified using a QIAquick 96 PCR Purification Kit (Qiagen) according to the manufacturer's protocol. Purified products were quantified using a Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies, Carlsbad, CA, USA). Equal amounts of amplicons from multiple samples were pooled and primer dimers removed via a GeneRead Size Selection Kit (Qiagen) according to the manufacturer's protocol. Pooled libraries were sequenced using an Illumina MiSeq instrument and a MiSeq v3 Reagent Kit (Illumina, San Diego, CA, USA).
After acquisition of Illumina paired-end reads, the bowtie-2 program (ver. 2-2.2.4) (22) was used to remove the reads mapped to PhiX 174 sequence and Genome Reference Consortium human build 37 (GRCh37). Thereafter, the 3 0 region of each read with a PHRED quality score of less than 17 was trimmed. Trimmed reads less than 150 bp in length with an average quality score of less than 25 or those lacking paired reads were also removed. Trimmed paired-end reads were combined using fastq-join script in EA-Utils (ver. 1.1.2-537) (23) . Potential chimeric sequences were removed by reference-based chimera checking in USEARCH (ver. 5.2.32) (24) and the gold database (http://drive5.com/ uchime/gold.fa) using UCHIME (24) .
Non-chimeric sequences were analyzed in a QIIME software package version 1.8.0 (25, 26) . Sequences were assigned to OTUs using USEARCH with the parameter of minimum cluster size: 2). A representative sequence was selected from each OTU, after which the representative sequence set was classified taxonomically using the BLAST program (ver. 2.2.22) with a 98.6% pairwise identity threshold and DDBJ 16S ribosomal RNA sequence data of prokaryotes (published October 2015).
Diversity analysis
a-Diversity indices (Shannon index, Chao1, number of observed species [number of OTUs] and PD whole tree) and distances between samples (UniFrac distance) were estimated using QIIME version 1.8.0 software.
Statistical analysis
All statistical analyses were conducted using SPSS version 23.0 statistical software (IBM, Armonk, NY, USA). Inter-group differences in relative abundance were analyzed using the Wilcoxon rank-sum test. Differences in the relative abundance of each bacterial taxon between the baseline and each time point in each group were analyzed using the Wilcoxon signed-rank test. Differences between the clusters in PCoA were analyzed using the x 2 test. Intra-and inter-group differences in a-diversity were analyzed by Student's ttest. Relationships between bacterial abundance and oral assessment variables were analyzed using Spearman's correlation. Two-sided P < 0.05 was considered to denote significance for all tests.
RESULTS
Participants
A flow chart of the study protocol is shown in Figure 1 . One of 47 individuals assessed for possible participation in the study was excluded on the basis of the exclusion criteria (viii). Forty-six subjects were randomized to the placebo group (n ¼ 22) or test group (n ¼ 24). One of the members of the test group did not complete the study.
Five participants in the placebo group and three in the test group failed to comply with the suggested intake rate (less than 75%). Therefore, 37 subjects with full analysis sets were included in the efficacy analysis. Their baseline characteristics of the full analysis set are listed in Table 1 . Three members of the placebo group and four of the test group used antibiotics during the study period; their post-antibiotic data after were treated as missing values. Supragingival plaque was collected from dentate subjects only. Four individuals in the placebo group and three in the test group were edentulous. The number of samples of supragingival plaque and tongue coating are summarized in Supplemental Table S1 .
Microbiota composition at the phylum level
The 16S rRNA gene amplicon analysis identified a total of 1,012,766 and 1,302,024 high-quality paired sequences obtained from 84 samples of supragingival plaque and 103 samples of tongue coating, respectively, with 12,056.7 AE 3,400.0 and 12,641.0 AE 3,322.6 (average AE SD) reads per sample, respectively. These were assigned 985 and 1,034 OTUs, respectively.
The phyla composing the microbiota in supragingival plaque and tongue coating are shown in Figure 2 . It was found that the following five phyla predominated in the microbiota in supragingival plaque and tongue coating: Firmicutes, Bacteroidetes, Fusobacteria, Proteobacteria and Actinobacteria. Although supragingival plaque and tongue coating had similar compositions at the phylum level, significant differences between supragingival plaque and tongue coating were identified by UniFrac principal coordinate analysis (PCoA, Supplemental  Fig. S2 ), suggesting that the compositions of supragingival plaque and tongue coating microbiota differ.
The composition of the microbiota at the phylum level did not change markedly after 4 and 8 weeks of ingesting the placebo and test tablets.
Changes in the relative abundance of bacterial species
Although there was no significant change at the phylum level, the relative abundance of several bacterial species changed significantly between the baseline and 8 weeks. These bacteria and their changes are summarized in Tables 2 (supragingival plaque) and 3 (tongue coating). The relative abundance of 10 and 11 bacterial species decreased or increased significantly, respectively, in supragingival plaque in the test group. In contrast, the relative abundance of only one and two bacterial species decreased or increased significantly, respectively, in the placebo group. In tongue coating, 14 and 15 bacterial species decreased or increased significantly, respectively, in the test group, whereas four and 13 bacterial species increased or decreased significantly, respectively, in the placebo group. In the test group, most of the supragingival plaque and tongue coating bacterial species that decreased significantly were gram-negative bacteria, whereas most of those that increased significantly were gram-positive bacteria. Their relative abundance is shown in Supplemental Table S3 . Bacterial species with significant intergroup differences are shown in Supplemental Table S4 .
Bacterial taxa were divided into a gram-positive group including Firmicutes (excluding the family Veillonellaceae) and Actinobacteria and a gramnegative group including Firmicutes (including the family Veillonellaceae), Bacteroidetes, Fusobacteria, Proteobacteria and Spirochaetes. In the test group, the total relative abundance of gram-positive organisms in tongue coating was significantly greater at 4 and 8 weeks than at baseline (Fig. 3c) , whereas the total relative abundance of gram-negative organisms decreased significantly at 4 and 8 weeks (Fig. 3d) . No significant changes in supragingival plaque were observed during the test period, the median of the total relative abundance of gram-positive and -negative organisms in the test group being higher and lower at 8 weeks that at baseline, respectively (Fig. 3a,b) .
The relative abundance of caries-associated bacteria (Streptococcus mutans and S. sobrinus) did not increase significantly in supragingival plaque and tongue coating after ingestion of either test or placebo tablet (Supplemental Table S5 ). Most opportunistic bacteria (Haemophilus parainfluenzae, Moraxella catarrhalis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, and S. pneumoniae) did not increase significantly (Supplemental Table S5 ). The relative abundance of Klebsiella pneumonia, which is an opportunistic pathogen, in tongue coating was significantly lower at 8 weeks that at baseline in the test group. The rate of detection of Candida sp. determined by culturing was low at baseline in both groups and continued to be low throughout the test period. The relative abundances are shown in Supplemental Table S3 . Bacterial species with significant inter-group differences are shown in Supplemental Table S4 .
Diversity of the microbiota
Changes in an a-diversity index, the Shannon index, in the microbiota of supragingival plaque and tongue coating are shown in Figure 4 . The Shannon index is an a-diversity measure that reflects both the abundance and evenness of the species present. The Shannon index was significantly lower in the microbiota of supragingival plaque in the test group than in the placebo group at 4 and 8 weeks (Fig. 4a) , whereas for the microbiota of tongue coating it did not differ significantly between the groups (Fig. 4b ). There were no significant intra-group differences between the groups for either site. The results of other a-diversity indices, including chao1, the number of observed species, and PD whole tree, were similar to those obtained by the Shannon index (Supplemental Fig. S6 ).
Oral microbiota and state of oral health
Correlations between bacterial abundance and oral assessment variables were analyzed in the full analysis set (Table 4) . In supragingival plaque, the total relative abundance of gram-positive organisms correlated Relative abundances are shown in Supplemental Table S3 . Bacterial species with significant inter-group differences are shown in Supplemental Table S4 .
negatively with the assessed oral health-related variables (O'Leary's PCR, BOP and total VSCs). In contrast, the total relative abundance of gram-negative organisms correlated positively with O'Leary's PCR, BOP and total VSCs. The Shannon index correlated positively with O'Leary's PCR, and PPD. The results were consistent when other a-diversity indices were calculated (Supplemental Table S7 ). In tongue coating, the total relative abundance of gram-positive organisms correlated with PPD and total VSCs. Furthermore, the relative abundance of several bacterial species that changed significantly in supragingival plaque and tongue coating also correlated with the assessed oral health-related variables (Supplemental Table S8 ). For example, the relative abundances of four periodontal species (Prevotella oris, Capnocytophaga gingivalis, Treponema sp. oral taxon 231, Prevotella buccae) that had decreased significantly in supragingival plaque correlated positively with some of these variables, including O'Leary's PCR, PPD and BOP. These bacteria were identified as periodontal pathogens. In contrast, the relative abundances of eight species (human intestinal firmicute CS13, Bifidobacterium pseudocatenulatum, [Ruminococcus] gnavus, bacterium IARFR575, [Clostridium] leptum, Roseburia inulinivorans, bacterium ic1379) that had increased significantly in supragingival plaque correlated negatively with some of the oral health-related variables. The some a-diversity score correlated negatively with the total relative abundance of grampositive organisms and positively with that of gramnegative organisms in supragingival plaque and tongue coating (Supplemental Table S9 ).
DISCUSSION
LF and LPO are antimicrobial proteins in saliva. Our previous clinical trial showed that long-term ingestion of LF and LPO-containing tablets significantly reduces the total number of bacteria as well as of P. gingivalis in supragingival plaque and tongue coating (14) . However, little information on their effects on other oral bacteria, including pathogens, indigenous bacteria and opportunistic bacteria, is available. Therefore, we here used a 16S rRNA gene sequencing approach to comprehensively analyze the oral microbiota of samples taken from our previous clinical trial (14) . The relationships between other a-diversity scores and assessed oral-health related variables are shown in Supplemental Table S7 . We compared the microbial compositions of supragingival plaque and tongue coating. UniFrac PCoA showed that the microbial communities are different in supragingival plaque and tongue coating, which is consistent with previous findings that supragingival plaque communities differ more than microbial communities from seven other oral sites, including tongue coating. (27) . Bacteria in supragingival plaque have been implicated in periodontal disease such as gingival inflammation and bacteria in tongue coating have been identified as a major source of oral malodor (28) . Therefore, the compositions of the microbiota of supragingival plaque and tongue coating need to be examined in more detail to enable evaluation of their effects on oral health.
In both supragingival plaque and tongue coating in the test group, most bacterial species that decreased or increased significantly were gram-negative and -positive, respectively. Similarly, the total relative abundance of gram-negative and -positive bacteria in tongue coating in the test group decreased and increased significantly, respectively. These results suggest that the test tablets promote a shift in oral microbiota of supragingival plaque and tongue coating from a gram-negativedominated community to a gram-positive-dominated community. Previous in vitro studies have found that the LPO system exerts bactericidal effects against gramnegative bacteria and bacteriostatic effects against grampositive bacteria (29) . The authors suggested that the cell walls of gram-positive organisms are more effective barriers against hypothiocyanite produced by the LPO system than those of gram-negative organisms. Moreover, Streptococci, gram-positive bacteria that predominate in the oral microbiota, are capable of neutralizing hypothiocyanite. In contrast, LF exerts antimicrobial effects against a wide range of pathogens (9); however, its selectivity against gram-positive and -negative bacteria has not yet been investigated. Therefore, we consider the microbial shift induced by the test tablets is more likely attributable to the selectivity of the LPO system rather than that of LF.
There is insufficient agreement on the criteria for a healthy oral microbiota; however, recent studies have found a relationship between the oral microbiota and state of oral health (1, 2, 4, 15, 16) . For example, in a large-scale population-based study on the salivary microbiome, Takeshita et al. found that high bacterial richness in salivary microbiomes correlated with poor oral health, evidenced by periodontitis, poor oral hygiene and the presence of decayed teeth (16) . Liu et al. reported that the oral microbiota in samples from persons with good oral health is dominated by grampositive bacteria, whereas that in those with periodontal disease is dominated by gram-negative bacteria, including many pathogenic species (15) .
In the present study, decreases in the total relative abundance of gram-negative bacteria in supragingival plaque correlated with deterioration of oral healthrelated variables, including O'Leary's PCR, BOP and total VSCs. In addition, at 8 weeks in the test group BOP had significantly decreased from baseline (14) . These results suggest that the microbial shift induced by the test tablets from a gram-negative-dominant to a grampositive-dominant community contributes to improvements in oral health.
Diversity indices of microbiota of supragingival plaque correlated positively with assessed oral healthrelated variables such as O'Leary's PCR and PPD. These results are consistent with the findings of a previous large-scale clinical study in which less a-diversity of the salivary microbiota was associated with better conditions for oral health such as a lower plaque index, less gingival bleeding and shallower periodontal pockets (16) . In the present study, the diversity indices of microbiota of supragingival plaque were significantly lower in the test than in the placebo group at 8 weeks, suggesting that long-term ingestion of the test tablets suppresses increases in microbial diversity of supragingival plaque related to deterioration in oral conditions. Repeated usage of antibiotics is not recommended because of potential issues associated with microbial substitution (6) . We confirmed that the test tablets did not induce increases in the relative abundance of opportunistic bacteria or rate of detection of Candida sp. The results of comparisons of the phylum composition suggest that ingestion of the test tablets does not markedly affect the overall structure of the microbiota in supragingival plaque and tongue coating. No adverse events related to the tablets were observed in any of the 46 study participants (14) . Thus, long-term use of the test tablets does not appear to result in microbial substitution. We consider that these tablet can be continuously and safely taken on a daily basis because LF and LPO are antimicrobial components of saliva.
Although previous studies have evaluated the oral microbiota after use of food or probiotics as described below, none have demonstrated beneficial effects on the whole oral microbiota. Use of xylitol gum reportedly decreases the abundance of S. mutans but does not affect the microbial composition of salivar (30) . Short-term consumption of lozenges containing Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. Lactis BB-12 reportedly decrease the amount of plaque without affecting the microbiota (31) . Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5239 for 12 weeks induces a shift in the microbiota composition of tooth biofilm; however, the biological relevance of this microbial shift has not yet been elucidated (32) . To the best of our knowledge, the present study is the first to use 16S rRNA gene high-throughput sequencing to demonstrate improvements in the microbiota of supragingival plaque and tongue coating through long-term ingestion of food.
In the present clinical study, we collected tongue coating and supragingival plaque, not subgingival plaque and saliva. This was a limitation of our study. A previous study suggested that long-term ingestion of LF 300 mg/ day and LPO 5.4 mg/day reduces the number of Fusobacterium in subgingival plaque (33) . Therefore, we consider the LF and the LPO-containing tablets our participants took to exert some effects on the microbiota of subgingival plaque. Further clinical studies are needed to validate these effects.
In conclusion, the results of the present clinical study suggest that the long-term ingestion of LF and LPOcontaining tablets promotes a shift from a highly diverse and gram-negative-dominated to a gram-positive-dominated community in the microbiota of supragingival plaque and tongue coating. This microbial shift may contribute to improvements in oral health, including improvements in oral malodor and gingival conditions.
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